Luciana Molinero to BRCA1 Protein
This is a "connection" page, showing publications Luciana Molinero has written about BRCA1 Protein.
Connection Strength
0.053
-
PARP inhibition with rucaparib alone followed by combination with atezolizumab: Phase Ib COUPLET clinical study in advanced gynaecological and triple-negative breast cancers. Br J Cancer. 2024 Sep; 131(5):820-831.
Score: 0.053